N/A N=647 Randomized Double-blind Health Services Research

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

Human Papilloma Virus Infection Type 11 · Human Papilloma Virus Infection Type 16 · Human Papilloma Virus Infection Type 18 · Human Papilloma Virus Infection Type 6 · Cervical Cancer

Bottom Line

View on ClinicalTrials.gov: NCT02551887 ↗

Enrolled (actual)

647

Serious AEs

0.0%

Results posted

Feb 2016

Primary outcome: Primary: First Dose HPV Vaccine Uptake — 118; 63; 117 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Automated Reminder (Behavioral); Automated Reminder Plus Script (Behavioral)
Age: Pediatric · 11+ yrs
Sex: All
Sponsor: Regenstrief Institute, Inc.
Primary completion: Apr 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY First Dose HPV Vaccine Uptake	118; 63; 117	—
SECONDARY Second Dose HPV Vaccine Uptake	20; 8; 17	—

Summary

Primary, Secondary, and Exploratory Objective(s): Primary objective: To evaluate the effect of interventions on 1st dose uptake of HPV vaccine.

Eligibility Criteria

Inclusion Criteria

Eligible Providers

All pediatricians and nurse practitioners who provide health care at the 5 CHICA clinics will be included in this study.

Eligible Patients

Males and females
11-14 years of age with no prior HPV vaccine doses administered
Eligible for Tdap and/or MCV4 vaccination at the visit.

Exclusion Criteria

Patients in the eligible age range who have already received one or more of the adolescent platform vaccines

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02551887). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.